RBBP9 and malignant colon neoplasm: Consistent with these results, we observed reduced growth of both the RBBP9-suppressed colon cancer cell line (MC38) and tumor organoids generated from ApcMin/+;Rbbp9-/- small intestinal tumors compared with their respective controls with normal RBBP9 expression (Figure 5E and F).